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ABSTRACT  Production  of GP140, a major component  of the extracellular  matrix of cultured  fibro- 
blasts,  is markedly decreased  in SV40 transformed cells  as compared with normal cells  (Carter,  W. 
G., 1982, J. Biol.  Chem., 257:13805-13815). To determine at what step the biosynthesis is inhibited, 
we compared  the  levels  of functional  mRNA  for  GP140  in  normal  and  transformed  fibroblasts. 
Translation of total  RNA from Wl38 cells  in a reticulocyte  lysate,  followed  by immunoprecipitation 
with affinity-purified  antibodies to GP140, yielded a single  polypeptide with an Mr of 125,000.  This 
polypeptide was identified as GP140 based on its immunoreactivity,  collagenase  sensitivity,  and co- 
migration  on polyacrylamide  gels with GP140 synthesized  by cells  in the presence of tunicamycin 
and  2,2'-bipyridyl.  No  cell-free  synthesis  of  GP140  was  observed  with  total  RNA  from  SV40 
transformed Wl38 cells,  indicating that these cells contain very low levels of GP140-specific  mRNA. 
The biosynthesis of GP140 might therefore be blocked at the transcriptional  level. 
GP140 is a major glycoprotein of the extracellular matrix of 
cultured  fibroblasts (1-4).  The protein  has been shown to 
form covalent and/or noncovalent interactions with several 
other matrix components including GP250, fibronectin, and 
collagen type I. When isolated under nonreducing conditions, 
GPI40 can promote stable attachment and spread fibroblasts 
in vitro (2).  This activity, however, is lost upon  reduction, 
suggesting that the correct conformation of the protein pro- 
vided by intact disulfide bonds is important for the interaction 
of GPI40 with the cell surface. A  soluble form of GP140, 
which differs from the  matrix  form in  its lower degree of 
intermolecular disulfide bonding, is found in the conditioned 
media of cultured fibroblasts (3, 4). 
GP140  contains  equal  amounts  of hydroxyproline  and 
hydroxylysine, indicating that it is a collagen-like protein (2). 
Recently, three different laboratories have demonstrated by 
immunological,  biochemical,  and  electron  microscopical 
techniques that GPI40 is related to type VI collagen (5-7), a 
dumbbell-shaped molecule with  a  short,  collagenous triple 
helix separating two large globular domains (8). 
Previous work  from this  laboratory has  established  that 
GP 140 is absent from the extracellular matrix of SV40 trans- 
formed fibroblasts and various human tumor cells, and that 
very little is found in the conditioned media of such cells (3, 
4).  The  loss of GPI40  appeared to  be due  to  a  decreased 
synthesis rather than an increased degradation, since matrix 
derived from normal cells was not degraded at an unusual 
rate in the presence of transformed cells, and since virtually 
no cytoplasmic precursor form of GP140  was detected  in 
transformed cells. The goal of the present study was therefore 
to determine at what step the production of GP140 may be 
inhibited.  We show by in vitro translation that the level of 
functional mRNA for GP140 is decreased more than 20-fold 
in SV40 transformed WI38 cells as compared with normal 
cells. The biosynthesis of GPI40 might thus be blocked at the 
transcriptional level. 
MATERIALS  AND  METHODS 
Cell Culture:  Normal fibroblasts from embryonic human lung (W138 
cells) and SV40 transformants of these cells (W138 VA 13 cells) were obtained 
from the American Type Culture Collection (Rockville, MD). A204 cells from 
a human rhabdomyosarcoma  and 251  MG cells from a human astrocytoma 
were provided by Dr. K. Alitalo (University of Helsinki). All cells were propa- 
gated at 37*C under an atmosphere of 5% CO2 in Dulbecco's modified Eagle's 
medium supplemented  with  10%  fetal calf serum,  100 U/ml penicillin, and 
100 ug/ml streptomycin.  For metabolic  labeling, the  cells were rinsed twice 
with methionine-free  medium containing  0.5  mg/ml bovine serum albumin 
instead of fetal calf serum, and incubated for 5-14 h in this medium with 100 
uCi/ml, 1,090 Ci/mmol [3~S]methionine  (New England Nuclear, Boston, MA). 
For metabolic labeling in the presence of 2 #g/ml tunicamycin  (Calbiochem- 
Behring Corp., La Jolla, CA) and 0.2 mM 2,2'-bipyridyl (Sigma Chemical Co., 
St. Louis, MO), cells were preincubated  with these inhibitors for 2-5 h before 
addition of [~SS]methionine. 
Cell-free Translation:  Total cellular RNA was extracted by the gua- 
nidine HC1 method (9) or by the SDS/proteinase K method ( l 0). A reticulocyte 
lysate was prepared from anemic rabbits and treated with micrococeal nuclease 
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19.6 ~l reticulocyte  lysate was incubated for 2 h at 30"C in a final volume of 
50 #l containing 100 #Ci [~SS]methionine  (1,090 Ci/mmol) (New England 
Nuclear), 50-800 #g/ml of total cellular RNA, 7.5 mM creatine phosphate, 
1.25 mM spermidine, 1.87 mM dithiothreitol, 88 mM potassium acetate, 0.3 
mM magnesium acetate, 23.4 #M of all amino acids except methionine, and 
18.7 mM HEPES (pH 7.6). Before addition to the translation reaction, the 
RNA was heated to 80"C for 6 s.  In some experiments, 100 U/ml of the 
ribonuclease  inhibitor RNasin (Promega Biotec, Madison, WI) was added. 
Immunoprecipitation:  Antisera  to a preparation of GPl40 from the 
matrix of WI38 cells were raised in rabbits (3) and affinity-purified  on Sepha- 
rose-immobilized  GPI40 that had been isolated from human placenta (5). A 
rabbit antiserum to vinculin was a generous  gift from Dr. L. R. Rohrschneider 
(Fred Hutchinson Cancer Research  Center, Seattle, WA). Proteins  were precip- 
itated from the translation mixtures (40-/~1  aliquots) or from the conditioned 
media of  WI38 cells  (250-~1  aliquots)  as described  (12). The amount of  antibody 
required for quantitative precipitation was determined in a previous experi- 
ment. When immunoprecipitation was successively  repeated with the same 
aliquot of translation mixture, only negligible  quantities of GPI40 were re- 
covered in the second precipitate. For control experiments,  nonspecific  rabbit 
immunoglobulins  (Sigma  Chemical  Co.) were used. Digestion  of the immuno- 
precipitates with bacterial collagenase  (315 U/mg, chromatographically  puri- 
fied) (Worthington,  Freehold,  NJ) was done in the presence  of 2 mg/ml bovine 
serum albumin as described  02). 
Gel  Electrophoresis:  Protein was analyzed on 7% SDS polyacryl- 
amide gels essentially  as described by Laemmli (13). Gels were fixed in 50% 
methanol, 10% acetic acid, allowed to swell to their original size in  10% 
methanol, 10% acetic acid, and exposed to Kodak X-Omat AR film (Eastman 
Kodak Co., Rochester,  NY) after we dried them on filter  paper. For quantitative 
comparison, areas corresponding  to radioactive  bands were excised from the 
dried gels, dissolved  in 0.2 ml of 70% perchloric  acid, 0.4 ml of 30% hydrogen 
peroxide (2-3 h at 75"C), and counted in 5 ml of Formula 963 scintillation 
fluid (New England Nuclear). 
RESULTS 
Synthesis of GP140 by Cells in Culture 
Affinity-purified antibodies to GP140 precipitated two ma- 
jor polypeptides from  the conditioned media of WI38 cells 
with apparent molecular weights of 140,000 and 240,000 on 
polyacrylamide gels  (Fig.  l,  lanes  1,  4,  and  7).  After  heat 
denaturation, the  lower  molecular weight  polypeptides was 
fully susceptible to digestion with bacterial collagenase, yield- 
ing fragments with  molecular weights  of 50,000-60,000;  in 
its native conformation, however,  the  polypeptide  partially 
resisted  digestion  with  collagenase  (Fig.  l,  lanes  1-3).  Im- 
munoreactivity, molecular weight, and collagenase sensitivity 
clearly establish the Mr 140,000 polypeptide as GP 140 (1-4). 
The  higher  molecular weight  polypeptide  was  only slightly 
affected by bacterial collagenase, even after heat denaturation. 
Thus,  this  polypeptide  shares  characteristics  with  GP250, 
another component  of the  extracellular matrix  of cultured 
fibroblasts (1-4), as well as with the procd  chain of type VI 
procollagen (8). Experiments designed to establish its identity 
are in progress. In addition to the two polypeptides, a  minor 
component with an Mr  190,000 was recovered in the immu- 
noprecipitates in variable amounts. Whether this material is 
derived from the Mr 240,000 polypeptide or whether it rep- 
resents a different entity is not yet known. 
Two explanations could account for the co-precipitation of 
the  Mr  240,000  polypeptide  with  GP140:  either  the  Mr 
240,000  polypeptide  cross-reacts  with  the  affinity-purified 
antibodies or  it  is  specifically or  nonspecifically bound  to 
GPI40. To address this question, we performed immunopre- 
cipitation after dissociation of the proteins in the conditioned 
media with SDS and dithiothreitol (Fig.  l, lanes 4-6).  Affin- 
ity-purified antibodies precipitated  only GPI40  from  such 
pretreated media. When dissociation was done in the absence 
of reducing agents, however, both GPI40 and the Mr 240,000 
FIGURE  1  Characterization of GP140 synthesized  by cells in cul- 
ture.  Wl38  cells were metabolically labeled with [3SS]methionine 
and GP140 was immunoprecipitated from the conditioned media. 
Immunoprecipitates were resolved on 7% polyacrylamide gels in 
the presence of mercaptoethanol and visualized  by autoradiogra- 
phy.  (Lanes l,  4,  and  7)  Immunoprecipitate obtained with  anti- 
GP140 antibodies; (lane 2) collagenase digest of the immunopre- 
cipitate; (lane 3) as for lane 2, but digestion performed after heating 
of the immunoprecipitate for 3 min to 100°C; (lane 5) immunopre- 
cipitate obtained from media that had been boiled in the presence 
of 0.1% SDS (3  min at  100°C);  (lane 6) as for lane 5,  but media 
boiled in the presence of 0.1% SDS and 10 mM dithiothreitol; (lane 
8)  immunoprecipitate obtained from media of cells grown in the 
presence of tunicamycin; {lane 9) as for lane 8, but cells grown in 
the  presence  of  tunicamycin  and  2,2'-bipyridyl.  GP140  and  its 
unglycosylated  (GP140*) and  unglycosylated  and  unhydroxylated 
(GP140**) forms  are identified in the right  margin. Arrowheads in 
the left margin indicate the positions  of migration of myosin  (Mr, 
200,000),  fl-galactosidase  (Mr,  116,000), phosphorylase  b  (Mr, 
93,000), serum albumin (Mr, 66,000), and ovalbumin (M, 45,000). 
polypeptide were recovered in the immunoprecipitate. Thus, 
the higher molecular weight polypeptide does not cross-react 
with our antibodies. 
GPI40 has been reported to contain carbohydrates as well 
as hydroxyproline and hydroxylysine (2).  To determine the 
effect of these posttranslational modifications on the electro- 
phoretic mobility of GPI40, we  used conditioned media of 
cells that had been cultured in the presence of specific inhib- 
itors  for  immunoprecipitation (Fig.  l,  lanes  7-9).  Tunica- 
mycin, a  potent inhibitor of N-glycosylation, increased the 
mobility of both  GP140  and  the  Mr  240,000  polypeptide. 
2,2'-Bipyridyl, which  inhibits hydroxylation  of prolyl  and 
lysyl residues, had an additional effect on GP140 but not on 
the Mr 240,000 polypeptides. The mobility of GPl40 synthe- 
sized  in  the  presence  of both  inhibitors corresponded  to  a 
molecular weight of 125,000.  The polypeptide still appeared 
as a  fuzzy band on polyacrylamide gels, suggesting that it is 
modified by additional mechanisms other than glycosylation 
and hydroxylation. Preliminary data indicate, however, that 
GP140 is neither sulfated nor phosphorylated. 
Cell-free Synthesis of GP140 
For in vitro protein synthesis, we prepared total RNA from 
WI38  cells and  translated  it in a  rabbit reticulocyte lysate. 
RAPID COMMUN,CAT,ONS  639 FIGURE  2  Cell-free  translation  of  GP140  and  of  vinculin.  Total 
cellular RNA from Wl38 cells (lanes 2, 4, 5,  7, 8, and  10) or SV40 
transformed Wl38  cells (lanes 3, 6,  9, and  11) was translated in a 
rabbit  reticulocyte  lysate.  Newly  synthesized  polypeptides were 
analyzed either directly (lanes  1-3)  or after  immunoprecipitation 
with  anti-GP140  antibodies  (lanes  4-6),  antivinculin  antiserum 
(lanes  7-9), or control immunoglobulins (lanes  10 and  ll) on 7% 
polyacrylamide gels.  Lane 1 depicts a control where no exogenous 
RNA was added to the reticulocyte lysate. The immunoprecipitates 
in lanes 5 and 8 were digested with bacterial collagenase. 
The RNA directed the synthesis of a great variety of polypep- 
tides with molecular weights of up to 200,000 as assessed by 
PAGE  (Fig.  2,  lanes  I-3).  Affinity-purified antibodies  to 
GP140  specifically precipitated an Mr  125,000  polypeptide 
from the translation mixture, whereas nonspecific immuno- 
globulins precipitated only minor low molecular weight ma- 
terial (Fig.  2,  lanes 4 and  I0).  The precipitated polypeptide 
was sensitive to digestion with bacterial collagenase, yielding 
a fragment with a molecular weight of -50,000 (Fig.  2, lane 
5). Based on immunological reactivity, collagenase sensitivity, 
and co-migration on polyacrylamide  gels with GP 140 synthe- 
sized by cells in the presence of tunicamycin and 2,2'-bipyr- 
idyl, we conclude that the Mr 125,000  polypeptide represents 
a  full-length translation product of GP140-specific mRNA. 
In vitro synthesis of GP 140 as determined by incorporation 
of  radioactivity into immunoprecipitable material was directly 
proportional to the amount of exogenous RNA added to the 
reticulocyte lysate between 50 and 400 #g/ml. Above 800 #g/ 
ml,  no  further increase  was observed.  As  had  been  noted 
above  for  GP140  synthesized  by  cells  in  culture,  GPI40 
translated in vitro always revealed a fuzzy band on polyacryl- 
amide gels.  This  may be  due  to  an  uncharacterized  post- 
translational modification occurring in the reticulocyte lysate, 
rather than to unspecific degradation or premature termina- 
tion during translation, since other polypeptides of the trans- 
lation mixture such as vinculin gave sharp bands on polyac- 
rylamide gels (see below). Addition of the ribonuclease inhib- 
itor  RNasin  had  no  effect.  Almost  identical  results  were 
observed with three different preparations of RNA that had 
been obtained by the SDS/proteinase K  or by the guanidine 
HCl method. 
640  RAPID  COMMUNICATIONS 
Absence of Functional mRNA for GP140 in 
Transformed Cells 
Previous  studies  have  indicated  that  the  production  of 
GPI40  is  markedly decreased  in  SV40  transformed WI38 
cells (WI38 VA13 cells) (3). We investigated therefore whether 
GP140-specific mRNA can be isolated from such cells. When 
translated in the  reticulocyte lysate, total RNA from WI38 
VAI 3 cells directed the synthesis of a variety of polypeptides 
similar  to  total  RNA  from  normal  cells  (Fig.  2,  lane  3). 
Although the overall incorporation of radioactivity into newly 
synthesized proteins was equal when the two RNA prepara- 
tions were used,  some specific differences were noted.  For 
quantitative comparison, we excised areas corresponding to 
discrete radioactive bands from the polyacrylamide gel and 
counted them in a liquid scintillation counter. Based on this 
method,  functional  mRNA  for an  Mr  95,000  protein  was 
increased twofold in WI38 VA13 cells, and functional mRNA 
for an Mr 45,000 protein (probably actin) was decreased 1.8- 
fold. 
Affinity-purified antibodies to GPI40 did  not precipitate 
any detectable material from the translation mixture contain- 
ing RNA from WI38 VAI3 cells (Fig. 2, lane 6). Since mRNA 
levels as low as one-twentieth the level found in normal cells 
can easily be detected by our method, the reduction ofGP140- 
specific mRNA in WI38 VA13 cells must be more than 20- 
fold. Altering the RNA concentration or adding the ribonu- 
clease inhibitor RNase had no effect. No in vitro translation 
of GP140 was observed, irrespective of whether the RNA had 
been prepared by the SDS/proteinase K  or by the guanidine 
HCI method. 
The  RNA  preparation  from transformed cells can direct 
cell-free synthesis of proteins other than GP140.  As an ex- 
ample we chose vinculin, a protein with a reported molecular 
weight of 130,000  (14) (Fig.  2,  lanes 7-9). Crude antiserum 
to vinculin precipitated a major polypeptide with a molecular 
weight of 125,000  and several minor components of higher 
and lower molecular weights from a translation mixture con- 
taining RNA from normal WI38 cells. The Mr 125,000  poly- 
peptide probably corresponds to a full-length translation prod- 
uct of vinculin-specific mRNA, whereas the minor compo- 
nents may represent unrelated  polypeptides that cross-react 
with  the  crude  antiserum.  As  expected,  vinculin  was  not 
susceptible to digestion with bacterial collagenase. When total 
RNA from SV40 transformed WI38 cells was translated in 
vitro, and then immunoprecipitated, the same polypeptide of 
Mr  125,000  was recovered.  Quantitation  revealed that  the 
mRNA activity for vinculin was reduced approximately three- 
fold in the transformed cells. 
We next looked for GP140-specific mRNA in cells derived 
from two spontaneous human tumors of mesodermal origin. 
Based on in vitro translation, cells from an astrocytoma (251 
MG cells) exhibited a 13-fold lower level ofmRNA for GPI40 
than normal WI38 cells, and cells from a rhabdomyosarcoma 
(A 204  cells)  exhibited a  20-fold lower level.  In both cases, 
however,  translation  products  of  GP140-specific  mRNA 
could readily be detected  (not shown). These reductions in 
mRNA activity correlate with the published observations that 
251 MG and A 204 cells do not produce any matrix form of 
GP140 and only minor quantities of the released form (4, 7). 
DISCUSSION 
Transformation of fibroblasts by viruses causes a number of 
cellular changes including alterations in cell growth and shape, and changes in the synthesis rate of  a discrete group of  proteins 
(see reference 15 for review). Two proteins whose synthesis is 
markedly reduced after viral transformation are fibronectin 
and collagen type I. This change appears to be specific, for 
the synthesis of most other cellular proteins is unaltered. 
Recently, one of us reported that production  of GPI40, 
another glycoprotein of the extracellular matrix, is decreased 
in  SV40 transformed fibroblasts to an extent  similar to or 
even higher than that of fibronectin and collagen type I (3). 
In this study, we demonstrated that this reduction can be fully 
accounted for by a decrease in the level of  translatable mRNA 
for GP140.  Many steps in RNA metabolism could play an 
active part  in  regulating  the  ultimate  steady state level of 
functional mRNA in the cytoplasm of a cell. Possible mech- 
anisms for a decrease in the mRNA activity ofGP140 include 
decreased transcription, increased degradation, or failure to 
process the mRNA to an active translatable form. It seems 
unlikely that the RNA preparations from transformed cells 
are contaminated with a specific inhibitor of translation that 
could cause a decrease in mRNA translation activity since (a) 
translation of other proteins including vinculin could readily 
be demonstrated; (b) several preparations of RNA that had 
been obtained by two different methods gave the same results; 
(c) additional extraction of the RNA with phenol/chloroform 
or addition of  the ribonuclease inhibitor RNasin had no effect; 
and (d) the RNA was always denatured before it was added 
to the translation reaction. 
In the case of fibronectin, it has been shown by in vitro 
translation and by use of a cloned cDNA probe that the level 
of fibronectin-specific mRNA is decreased in  virally trans- 
formed fibroblasts to  -10%  of that in  normal cells (9, 15, 
16). Similar techniques have been used to demonstrate that 
the decrease of type I  collagen  synthesis in  Rous  sarcoma 
virus transformed fibroblasts is due to a  10-fold reduction in 
the level of collagen-specific mRNA (9,  10,  15,  17,  18). Since 
a thermosensitive mutant of the Rous sarcoma virus induces 
a drop of collagen mRNA levels only at the permissive but 
not at the nonpermissive temperature, it was suggested that 
the control of collagen synthesis occurs at the transcriptional 
level (17,  18). This conclusion is supported by the fact that 
an unrelated bacterial gene linked to the collagen promotor 
is regulated in a similar way as the collagen gene after viral 
transformation (19). 
A reduction in the biosynthesis of GP140 may have pro- 
found effects on the adhesive properties of transformed fibro- 
blasts, since GPI40 is known to promote cell attachment land 
cell  spreading (2).  Furthermore,  low levels of GP140  may 
disturb the integrity of the extracellular matrix, for GP 140 is 
normally associated  with  other  matrix  components  (1-4). 
Several publications have appeared supporting the idea that 
GP140 represents a subunit of type VI collagen (5-7). Type 
VI collagen on the other hand was shown to be composed of 
three different polypeptide chains (20). It would therefore be 
interesting to investigate whether all three subunits of type VI 
collagen are coordinately regulated in transformed fibroblasts, 
or whether any of the subunits is preserved during transfor- 
mation. A covalent interaction of GP140 with an Mr 240~000 
polypeptide is indicated  by the  co-precipitation of the two 
proteins from the conditioned media of WI38 cells (Fig.  l, 
lanes 4-6).  The possibility that the polypeptides covalently 
linked to GPI40 is identical to GP250, another component 
of the extracellular matrix of cultured fibroblasts (1-4), or to 
the proal chain of type VI procollagen (8) is currently under 
investigation. Immunoblotting experiments have previously 
revealed that GP250 is also absent from the matrix of trans- 
formed fibroblasts; yet transformed fibroblasts secrete a solu- 
ble form of  GP250 into the culture medium (3). We attempted 
to correlate the level of functional mRNA of GP250 with that 
of GP140.  Cell-free synthesis of GP250,  however, was not 
successful using the rabbit reticulocyte lysate system as has 
been reported for fibronectin (21).  Such  problems will  cer- 
tainly be overcome by preparation of specific cDNA probes 
to this new class of extracellular matrix proteins. 
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